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SKIN CARCINOGENESIS. MECHANISMS AND HUMAN RELEVANCE. Edited by Thomas J.
Slaga, Andre J.P. Klein-Szanto, R.K. Boutwell, Donald E. Stevenson, Hugh L.
Spitzer, and Bob D'Motto. New York, Alan R. Liss, Inc., 1989. 424 pp. $84.00.
Skin Carcinogenesis. Mechanisms and Human Relevance is a compilation of the
proceedings of the conference "Dermal Carcinogenesis: Research Directions for
Human Relevance," held in Austin, Texas, December 1-4, 1987. The first section of
the book, "Overview," discusses various models for thestudyofskin carcinogenesis and
their relevance to human disease. These chapters contain very basic, conceptual
information, providing good working definitions of terms such as "tumor," "papillo-
ma," and "carcinogen." The remainder of the book is composed of studies, presented
at the Austin meeting, which have been grouped into sections entitled "Biological
Aspects," "Cellular and Molecular Aspects," and "Biochemical Aspects." While the
studies in a given section do tend to focus on a specific aspect ofcarcinogenesis, there is
some overlap, which is inevitable when categorizing studies ofthis nature. There is also
variation in the depth of the papers presented, with some resembling review articles
and others detailing current research findings.
One of the most enjoyable aspects of the book is the inclusion of questions asked of
the authors after their presentations, which not only provides additional information,
but allows one to judge how these studies were received by the participants in the
conference.
The last section ofthe book, "Applications," is composed ofstudies aimed primarily
at using information gained through animal studies in theprevention ofhuman tumors,
which is the ultimate goal of much ofthe work in this volume. While this book nicely
ties together conceptual models of skin carcinogenesis, specific research using these
models, and applications ofrecent research tothe prevention ofhuman cancer, it is best
suited to individuals with specific interests in studying skin carcinogenesis, and not to
those whose interests are more clinically oriented.
STEVEN A. KOLENIK III
MedicalStudent
Yale UniversitySchool ofMedicine
CLINICAL GYNECOLOGIC ONCOLOGY. 3rd Edition. By Philip J. DiSaia and William T.
Creasman. St. Louis, MO, The C.V. Mosby Company, 1989. 712 pp. No price.
It has been five years since the second edition of Clinical Gynecologic Oncology was
published, and the authors are to be commended on having updated a tremendously
accessible and useful textbook.
The study ofgynecologic oncology is broad and varied. It encompasses both benign
and malignant ovarian tumors, and carcinoma ofthe uterine cervix and endometrium.
Not only are these tumors important epidemiologically, but they have provided the
field of oncology as a whole with several important paradigms. The use of the
Papanicolaou smear provides an exampleofhow mass screening programs can improve
our management ofmalignancy, and the growing awareness of how human papilloma
virus (HPV) may induce cervical neoplasia may provide insights into broader issues of
viral carcinogenesis.
Despite the broader implications of research in these areas, however, gynecologic340 BOOK REVIEWS
oncology is a clinical discipline requiring the thorough knowledge of a large body of
data. The authors have done an excellent job at presenting this data in a clear,
well-written, and well-referenced manner. The book is organized into 14 chapters,
primarily by site. Several appendices, including reviews ofstaging and basic radiother-
apeutic principles, are provided at the end ofthe book. Each chapter is preceded by an
outline and is clearly divided into subsections. Illustrations and tables are clear and
useful. The text itselfflows well, with a uniformity ofstyle from chapter to chapter.
This text will be valuable not only to gynecologic oncologists, but to gynecologic
residents and gynecologists in practice. It will also be a useful addition to the library of
medical oncologists and radiation oncologists.
SETH A. ROSENTHAL
Department ofRadiation Oncology
University ofPennsylvania
Philadelphia, Pennsylvania